ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,824Medicare Part D Prescriptions Filled, Including Refills

Rank: 48 out of 1004

$697K Total Retail Price of All Prescriptions

Rank: 19 out of 1004

351 Patients Receiving at Least One Drug in Part D
85% Patients 65 Years and Older
25% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Massachusetts
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

4% of this provider’s 351 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

5% of this provider’s 351 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 19%.

Prescription Price

$71 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Massachusetts
ATORVASTATIN CALCIUM 477 443 92 1 7
SIMVASTATIN 397 328 63 2 2
LISINOPRIL 387 348 58 3 1
LEVOTHYROXINE SODIUM 369 344 55 4 4
FUROSEMIDE 302 281 60 5 9
METOPROLOL SUCCINATE 272 247 39 6 13
WARFARIN SODIUM 247 242* 30 7 11
ATENOLOL 240 235* 40 8 10
OMEPRAZOLE 221 196 37 9 3
LOSARTAN POTASSIUM 221 216* 35 9 21
AMLODIPINE BESYLATE 208 203* 40 11 5
LORAZEPAM 197 163 35 B 12 17
CRESTOR 195 156 36 13 38
METOPROLOL TARTRATE 194 130 30 14 12
PRAVASTATIN SODIUM 189 177 37 15 16
LISINOPRIL-HYDROCHLOROTHIAZIDE 182 156 30 16 41
HYDROCHLOROTHIAZIDE 176 164 32 17 6
TAMSULOSIN HCL 121 105 19 18 29
FLUTICASONE PROPIONATE 120 100 37 19 26
DIOVAN 119 119 18 20 51
KLOR-CON M20 117 88 22 21 84
GABAPENTIN 103 68 22 22 14
ADVAIR DISKUS 101 89 17 23 46
VALSARTAN-HYDROCHLOROTHIAZIDE 86 81* 14 24 150
PROAIR HFA 85 60 22 25 19
SYNTHROID 81 76* 16 26 98
CYMBALTA 81 65 14 26 54
AMLODIPINE BESYLATE-BENAZEPRIL 78 <11 <11 28 154
LOSARTAN-HYDROCHLOROTHIAZIDE 76 50 12 29 121
SPIRIVA 74 69* 12 30 45
METFORMIN HCL 73 60 13 31 8
PREDNISONE 72 67* 40 32 47
CLOPIDOGREL 70 70 12 33 33
CARVEDILOL 68 68 11 34 59
GLIPIZIDE ER 67 <11 <11 35 91
DEXILANT 66 43 11 36 111
METFORMIN HCL ER 59 44 13 37 48
SERTRALINE HCL 59 54* 15 37 22
MONTELUKAST SODIUM 57 <11 <11 39 69
ZOLPIDEM TARTRATE 54 <11 <11 40 36
FLUOXETINE HCL 51 33 11 41 44
DIGOX 51 <11 <11 41 81
FINASTERIDE 50 <11 <11 43 66
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.